Sickness Behavior in Community-Dwelling Elderly: Associations With Impaired Cardiac Function and Inflammation

Biological Research for Nursing

Volumn 16, Issue 1, 2014, Pages 105-113

  Johansson, Peter ^a,b   Riegel, Barbara ^c,d   Svensson, Erland ^e   Broström, Anders ^a,f   Alehagen, Urban ^a,d   Dahlström, Ulf ^a,d   Jaarsma, Tiny ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b Department of Social and Welfare Studies ^*  (Sweden)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LINKÖPING UNIVERSITY   (Sweden)

^e SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

^f JÖNKÖPING UNIVERSITY   (Sweden)

Author keywords

elderly; heart failure; inflammation; sickness behavior

Indexed keywords

AGED; ARTICLE; FEMALE; HEART FAILURE; HEART FUNCTION TEST; HUMAN; ILLNESS BEHAVIOR; INFLAMMATION; MALE; PATHOPHYSIOLOGY; THEORETICAL MODEL;

ELDERLY; HEART FAILURE; INFLAMMATION; SICKNESS BEHAVIOR;

AGED; FEMALE; HEART FUNCTION TESTS; HUMANS; ILLNESS BEHAVIOR; INFLAMMATION; MALE; MODELS, THEORETICAL;

EID: 84890766461     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800412466170     Document Type: Article

References (64)

1. Adamopoulos S.,Parissis J.,Kroupis C.,Georgiadis M.,Karatzas D.,Karavolias G.,Kremastinos D. Th.Physical training reduces peripheral markers of inflammation in patients with chronic heart failure.European Heart Journal. 2001;22:791-797.
2. Alehagen U.,Goetze J. P.,Dahlstrom U.Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.Clinical Chimica Acta. 2007;382:8-14.
3. Alehagen U.,Lindstedt G.,Eriksson H.,Dahlstrom U.Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care.Clinical Chemistry. 2003;49:1337-1346.
4. Al-shair K.,Kolsum U.,Dockry R.,Morris J.,Singh D.,Vestbo J.Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD.Respiratory Research. 2011;12:3.
5. Anand I. S.,Latini R.,Florea V. G.,Kuskowski M. A.,Rector T.,Masson S.,Cohn J. N.C-reactive protein in heart failure: Prognostic value and the effect of valsartan.Circulation. 2005;112:1428-1434.
6. Anker S. D.,von Haehling S.Inflammatory mediators in chronic heart failure: An overview.Heart. 2004;90:464-470.
7. Bjelland I.,Dahl A. A.,Haug T. T.,Neckelmann D.The validity of the hospital anxiety and depression scale. An updated literature review.Journal of Psychosomatic Research. 2002;52:69-77.
8. Bondia-Pons I.,Ryan L.,Martinez J. A.Oxidative stress and inflammation interactions in human obesity.Journal of Physiology and Biochemistry. 2012;:.
9. Bower J. E.Cancer-related fatigue: Links with inflammation in cancer patients and survivors.Brain, Behavior, and Immunity. 2007;21:863-871.
10. Bower J. E.,Ganz P. A.,Aziz N.,Fahey J. L.Fatigue and proinflammatory cytokine activity in breast cancer survivors.Psychosomatic Medicine. 2002;64:604-611.
11. Bower J. E.,Ganz P. A.,Irwin M. R.,Kwan L.,Breen E. C.,Cole S. W.Inflammation and behavioral symptoms after breast cancer treatment: Do fatigue, depression, and sleep disturbance share a common underlying mechanism?.Journal of Clinical Oncology. 2011;10:3517-3522.
12. Brostrom A.,Johansson P.Sleep disturbances in patients with chronic heart failure and their holistic consequences-What different care actions can be implemented?.European Journal of Cardiovascular Nursing. 2005;19:183-197.
13. Brostrom A.,Stromberg A.,Dahlstrom U.,Fridlund B.Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure.Journal of Cardiovascular Nursing. 2004;19:234-242.
14. Clerico A.,Giannoni A.,Vittorini S.,Passino C.Thirty years of the heart as an endocrine organ: Physiological role and clinical utility of cardiac natriuretic hormones.American Journal of Physiology. Heart and Circulatory Physiology. 2011;301:H12-H20.
15. Cole M. G.,Dendukuri N.Risk factors for depression among elderly community subjects: A systematic review and meta-analysis.American Journal of Psychiatry. 2003;160:1147-1156.
16. Collado-Hidalgo A.,Bower J. E.,Ganz P. A.,Cole S. W.,Irwin M. R.Inflammatory biomarkers for persistent fatigue in breast cancer survivors.Clinical Cancer Research. 2006;12:2759-2766.
17. Dantzer R.Cytokine, sickness behavior, and depression.Neurologic Clinics. 2006;24:441-460.
18. Dantzer R.,O'Connor J. C.,Freund G. G.,Johnson R. W.,Kelley K. W.From inflammation to sickness and depression: When the immune system subjugates the brain.Nature Reviews Neuroscience. 2008;9:46-56.
19. Dirmaier J.,Steinmann M.,Krattenmacher T.,Watzke B.,Barghaan D.,Koch U.,Shulz H.Non-pharmacological treatment of depressive disorders: A review of evidence-based treatment options.Reviews on Recent Clinical Trials. 2012;7:141-149.
20. Ekman I.,Cleland J. G.,Swedberg K.,Charlesworth A.,Metra M.,Poole-Wilson P. A.Symptoms in patients with heart failure are prognostic predictors: Insights from COMET.Journal of Cardiac Failure. 2005;11:288-292.
21. Falk K.,Patel H.,Swedberg K.,Ekman I.Fatigue in patients with chronic heart failure-A burden associated with emotional and symptom distress.European Journal of Cardiovascular Nursing. 2009;8:91-96.
22. Hunt K. J.,Walsh B. M.,Voegeli D.,Roberts H. C.Inflammation in aging part 1: Physiology and immunological mechanisms.Biological Research for Nursing. 2010a;11:245-252.
23. Hunt K. J.,Walsh B. M.,Voegeli D.,Roberts H. C.Inflammation in aging part 2: Implications for the health of older people and recommendations for nursing practice.Biological Research for Nursing. 2010b;11:253-260.
24. Jiang W.,Krishnan R.,Kuchibhatla M.,Cuffe M. S.,Martsberger C.,Arias R. M.,O'Connor C. M.Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).American Journal of Cardiology. 2011;107:545-551.
25. Johansson P.,Alehagen U.,Svanborg E.,Dahlstrom U.,Brostrom A.Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness.Sleep Medicine. 2009;10:1005-1011.
26. Johansson P.,Dahlstrom U.,Alehagen U.Depressive symptoms and six-year cardiovascular mortality in elderly patients with and without heart failure.Scandinavian Cardiovascular Journal. 2007;41:299-307.
27. Johansson P.,Lesman-Leegte I.,Svensson E.,Voors A.,van Veldhuisen D. J.,Jaarsma T.Depressive symptoms and inflammation in patients hospitalized for heart failure.American Heart Journal. 2011;161:1053-1059.
28. Kelley K. W.,Bluthe R. M.,Dantzer R.,Zhou J. H.,Shen W. H.,Johnson R. W.,Broussard S. R.Cytokine-induced sickness behavior.Brain, Behavior, and Immunity. 2003;17:S112-S118.
29. Koukouvou G.,Kouidi E.,Iacovides A.,Konstantinidou E.,Kaprinis G.,Deligiannis A.Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure.Journal of Rehabilitation Medicine. 2004;36:36-41.
30. Lesman-Leegte I.,Jaarsma T.,Sanderman R.,Linssen G.,van Veldhuisen D. J.Depressive symptoms are prominent among elderly hospitalised heart failure patients.European Journal of Heart Failure. 2006;8:634-640.
31. Lesman-Leegte I.,van Veldhuisen D. J.,Hillege H. L.,Moser D.,Sanderman R.,Jaarsma T.Depressive symptoms and outcomes in patients with heart failure: Data from the COACH study.European Journal of Heart Failure. 2009;11:1202-1207.
32. Liljenberg B.,Almqvist M.,Hetta J.,Roos B. E.,Agren H.The prevalence of insomnia: The importance of operationally defined criteria.Annals of Clinical Research. 1988;20:393-398.
33. Maeda K.,Tsutamoto T.,Wada A.,Mabuchi N.,Hayashi M.,Tsutsui T.,Kinoshita M.High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.Journal of the American College of Cardiology. 2000;36:1587-1593.
34. Maes M.,Mihaylova I.,Leunis J. C.Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): Indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability.Journal of Affective Disorders. 2007;99:237-240.
35. Mallon L.,Broman J. E.,Hetta J.Sleep complaints predict coronary artery disease mortality in males: A 12-year follow-up study of a middle-aged Swedish population.Journal of Internal Medicine. 2002;251:207-216.
36. Mallon L.,Hetta J.A survey of sleep habits and sleeping difficulties in an elderly Swedish population.Uppsala Journal of Medical Science. 1997;102:185-197.
37. McMurray J. J.,Adamopoulos S.,Anker S. D.,Auricchio A.,Bohm M.,Dickstein K.,Ponikowski P.2012 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.European Heart Journal. 33:1787-1847.
38. McMurray J. J.,Kjekshus J.,Gullestad L.,Dunselman P.,Hjalmarson A.,Wedel H.,Wikstrand J.Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the controlled rosuvastatin multinational trial in heart failure (CORONA): A retrospective analysis.Circulation. 2009;120:2188-2196.
39. Milani R. V.,Lavie C. J.,Mehra M. R.,Ventura H. O.Impact of exercise training and depression on survival in heart failure due to coronary heart disease.American Journal of Cardiology. 2011;107:64-68.
40. Myers J. S.Proinflammatory cytokines and sickness behavior: Implications for depression and cancer-related symptoms.Oncology Nursing Forum. 2008;35:802-807.
41. Newman A. B.,Enright P. L.,Manolio T. A.,Haponik E. F.,Wahl P. W.Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: The cardiovascular health study.Journal of the American Geriatrics Society. 1997;45:1-7.
42. O'Connor C. M.,Jiang W.,Kuchibhatla M.,Silva S. G.,Cuffe M. S.,Callwood D. D.,Krishnan R.Safety and efficacy of sertraline for depression in patients with heart failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.Journal of the American College of Cardiology. 2010;56:692-699.
43. Ormstad H.,Aass H. C.,Amthor K. F.,Lund-Sorensen N.,Sandvik L.Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients.Journal of Neurology. 2011;258:670-676.
44. Orre I. J.,Murison R.,Dahl A. A.,Ueland T.,Aukrust P.,Fossa S. D.Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.Brain, Behavior, and Immunity. 2009;23:868-874.
45. Pasic J.,Levy W. C.,Sullivan M. D.Cytokines in depression and heart failure.Psychosomatic Medicine. 2003;65:181-193.
46. Penninx B. W.,Kritchevsky S. B.,Yaffe K.,Newman A. B.,Simonsick E. M.,Rubin S.,Pahor M.Inflammatory markers and depressed mood in older persons: Results from the health, aging and body composition study.Biological Psychiatry. 2003;54:566-572.
47. Pinto A.,Di Raimondo D.,Tuttolomondo A.,Butta C.,Milio G.,Licata G.Effects of physical exercise on inflammatory markers of atherosclerosis.Current Pharmaceutical Design. 2012;18:4326-4349.
48. Rosner M. H.,Ronco C.,Okusa M. D.The role of inflammation in the cardio-renal syndrome: A focus on cytokines and inflammatory mediators.Seminars in Nephrology. 2012;32:70-78.
49. Sandek A.,Bjarnason I.,Volk H. D.,Crane R.,Meddings J. B.,Niebauer J.,Rauchhaus M.Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure.International Journal of Cardiology. 2010;157:80-85.
50. Schreiber J. B.Core reporting practices in structural equation modeling.Research in Social & Adminstrative Pharmacy. 2008;4:83-97.
51. Schubert C.,Hong S.,Natarajan L.,Mills P. J.,Dimsdale J. E.The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review.Brain, Behavior, and Immunity. 2007;21:413-427.
52. Sherwood A.,Blumenthal J. A.,Trivedi R.,Johnson K. S.,O'Connor C. M.,Adams K. F.,Hinderliter A.Relationship of depression to death or hospitalization in patients with heart failure.Archives of Internal Medicine. 2007;167:367-373.
53. Shih H.,Lee B.,Lee R. J.,Boyle A. J.The aging heart and post-infarction left ventricular remodeling.Journal of the American College of Cardiology. 2011;57:9-17.
54. Skobel E.,Norra C.,Sinha A.,Breuer C.,Hanrath P.,Stellbrink C.Impact of sleep-related breathing disorders on health-related quality of life in patients with chronic heart failure.European Journal of Heart Failure. 2005;7:505-511.
55. Smith O. R.,Kupper N.,de Jonge P.,Denollet J.Distinct trajectories of fatigue in chronic heart failure and their association with prognosis.European Journal of Heart Failure. 2010;12:841-848.
56. Stordal E.,Mykletun A.,Dahl A. A.The association between age and depression in the general population: A multivariate examination.Acta Psychiatrica Scandinavica. 2003;107:132-141.
57. Sullivan M.,Karlsson J.,Ware J. E.The Swedish SF-36 health survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden.Social Science & Medicine. 1995;41:1349-1358.
58. Torre-Amione G.,Kapadia S.,Benedict C.,Oral H.,Young J. B.,Mann D. L.Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD).Journal of the American College of Cardiology. 1996;27:1201-1206.
59. Tsutamoto T.,Hisanaga T.,Wada A.,Maeda K.,Ohnishi M.,Fukai D.,Kinoshita M.Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.Journal of the American College of Cardiology. 1998;31:391-398.
60. von Kanel R.,Dimsdale J. E.,Ancoli-Israel S.,Mills P. J.,Patterson T. L.,McKibbin C.,Grant I.Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease.Journal of the American Geriatrics Society. 2006;54:431-437.
61. Ware J. E.,Sherbourne C. D.The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.Medical Care. 1992;30:473-483.
62. Wirtz P. H.,Hong S.,Redwine L. S.,Tafur J.,Rutledge T.,Ziegler M. G.,Mills P. J.Depressive symptoms are associated with soluble P-selectin reactivity to acute exercise in heart failure.Biological Psychiatry,65. 2008;:801-807.
63. Wirtz P. H.,Redwine L. S.,Linke S.,Hong S.,Rutledge T.,Greenberg B. H.,Mills P. J.Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients.Brain, Behavior, and Immunity. 2009;24:366-369.
64. Zigmond A. S.,Snaith R. P.The hospital anxiety and depression scale.Acta Psychiatrica Scandinavica. 1983;67:361-370.